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ABSTRACT  
The hydrazone; N-[(3-chloro-4-nitro-phenyl) methyleneamino] pyridine-4-carboxamidine (H) was selected for in silico toxicological and in vitro 
bactericidal studies. Toxicological investigation was carried out using software program, such as eMolTox and Gusar, for the toxic substructure 
determination, and acute rat toxicity prediction respectively. In vitro bactericidal effect evaluation was investigated using tow marine 
pathogenic bacteria; Vibrio anguillarum and Photobacterium damselae. Computational results determinate toxicophores of (H), which are nitro-
aromatic part, hydrazine group, and quaternary carbon, were predicted as responsible for Idiosyncratic toxicity metabolic activation, covalent 
bond with DNA, and hepatotoxicity respectively. In addition, the predicted LD50 of (H) are 1086, 244, 1816, and 823.40 mg/kg in 
intraperitenial, intravenous, oral and subcutaneous administration respectively. For bactericidal results, H exhibited an excellent effect with 
inhibition percentages of 98.65 and 98.83% at the concentrations of 1000 and 500 µg/mL against Vibrio anguillarum respectively, the same 
effect was demonstrated against Photobacterium damselae with inhibition percentages of 97.74 and 97.98 % at the same concentrations. For 
anti-tubercular effect prediction, results revealed that H has an excellent effect with probability percentage of 84.6%.    
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INTRODUCTION  
Heterocyclic hydrazones present in many structures, with 
biological and pharmacological interest. They are a particular 
class of the Schiff base family, play an important role in 
medicinal chemistry. This class of compounds has excellent 
antibacterial, antifungal, antimicrobial and anticonvulsant 
activity1. In this context, heterocyclic hydrazones derived 
from the anti-tubercular drug; isoniazid (IZD) showed anti-
tuberculosis activity against Mycobacterium tuberculosis, and 
some of these compounds are more active and less toxic than 
isoniazid2. For these reason, our objective is to evaluate the 
toxicity, anti-tubercular activity and the antibacterial effect 
of new hydrazone derived from isoniside; N-[(3-chloro-4-
nitro-phenyl) methyleneamino] pyridine-4-carboxamidine 
(H) (Scheme 1).   
Scheme 1: Structure of H 
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MATERIAL AND METHODS 
All chemicals and reagents used throughout this study were 
obtained from commercial sources and used without further 
purification; Isoniazid (BHD chemicals Ltd Poole England). 
Bacterial strains 
The antibacterial activity of H was tested against: 
Photobacterium damselae subsp. piscicida SK 223/04 (CECT 
7198), Vibrio anguillarum 16 /00. The strains were donned 
by Dr. MA Moriñigo from the University of Málaga (Spain). 
Antibacterial activity evaluation  
Two pathogenic marine bacteria Vibrio anguillarum and 
Photobacterium damselae, were employed to estimate the 
bactericidal effect of H. The bacteria were grown on tryptic 
soy agar (TSA) at 25 ° C. After 18h, colonies of 1 to 2 mm 
were diluted in 5 mL of liquid culture medium (TSB) and 
cultured for 16 h at 25 ° C. The antimicrobial activity of H 
was determined by evaluating their effects on bacterial 
growth curves; 10 μL aliquots of each of the bacterial 
dilutions (1/10) were placed in 96-well flat-bottomed plates 
(Nunc) and incubated with equal volumes of H 
(concentration of 1000 and 500 μg/mL) for two hours. Then 
the absorbance of the samples was measured at 620 nm 
(BMG, Star GalaxyFluoro) at 30 minute intervals for 24 h at 
25 ° C. Samples without bacteria were used as blanks 
(negative control). Samples without H were used as positive 
control3. 
Toxicity predictions 
The online software programs used for toxicological studies 
are summarized in the following Table 1
 
Table 1: Online software programs for toxicity and bioactivity prediction of H and IZD 
Online software programs  Toxicity prediction 
e-MolTOX4  
(http://xundrug.cn/moltox) 
Toxic substructure predictions 
ProToxII5  
(http://tox.charite.de/protox II) 
Mutagenicity 
 
GUSAR eco-toxicity6 
http://www.pharmaexpert.ru/GUSAR/AcuToxPredict/.  
Acute rat toxicity  
 
Pass online tool7 
(http://cactus.nci.nih.gov/ncidb2/) 
Anti-tubercular activity 
 
RESULTS AND DISCUSSION 
Toxic substructure prediction 
Drug undesirables and toxic effects were traduced by 
unfavorable reactions affecting human organs, inducing 
harmful effects, are the principle problems in drug discovery 
and development8. These toxic actions can be related to 
chemical structures, or a part of the structures which defined 
by substructures or toxicophores, which could be an atom or 
fragments of chemical structure9. In order to predict the 
toxicity of IZD and its derivative H, Table 2, represents toxic 
substructures (in red color) and their adverse effects. The 
obtained results defined the toxic fragment in common of all 
investigated compounds; the hydrazine group (-NH-N-), 
predicted as responsible in hepatotoxicity effect induction. In 
addition to the hepatotoxic effect, the hydrazone has other 
toxic substructures: the nitro-aromatic part of H, presents 
the covalent bond with DNA, in the quaternary carbon atom, 
the nitro group bond with quaternary carbon, presents 
toxicity metabolic activation.  
 
Table 2: Toxic substructure prediction of IZD and H 
Compounds Toxic substructure Alert name 
 
IZD 
 
Covalent bind with DNA 
Hepatotoxicity  
 
 
 
H 
 
 
Covalent bind with DNA 
 
Idiosyncratic toxicity metabolic 
activation  
 
Hepatotoxicity 
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Acute rat toxicity prediction 
The major advantage of computational approaches for the 
acute toxicity and the toxicity classification of the 
investigated hydrazone, is to give important information 
before they are synthesized. Additionally, due to the ethical 
consideration, the time consumption and the high cost in 
animal models, the computational methods were used as a 
substitute in the in vivo toxicological studies.       
LD50 values and the predicted toxicity class of the IZD and its 
derivative were predicted by GUSAR software in rodent with 
different administration routes (intraperitoneal, 
intravenous, oral and subcutaneous). Results in Table 3, 
showed that the intraperitoneal route was the low toxic way 
of H with LD50 value of 1086 mg/kg, classified in the class 5, 
the LD50 of the investigated hydrazone in oral administration 
route were 1816 mg/kg. 
 
Table 3: Acute rat toxicity prediction of IZD and H. 
Compounds  Administration route LD50 
log10(mmol/kg) 
LD50 
(mg/kg) 
Predicted 
toxicity class 
 
 
INH 
Intraperitoneal (IP)  0.354 309.600 4 
Intravenous (IV) 0.271 256.100 4 
Oral administration  0.817 899.70 4 
Subcutaneous (SC) 0.326 290.20 4 
 
 
H 
 
Intraperitoneal (IP)  0.552 1086.00 5 
Intravenous (IV) -0.096 244.00 4 
Oral administration  0.775 1816.00 4 
Subcutaneous (SC) 0.432 823.40 4 
 
Mutagenicity prediction 
Mutagenicity is defined as the induction of changes in genes 
and/or chromosomes that are permanent or transmissible in 
cells or organisms10. Probability of IZD and its derivatives to 
introduce genetic changes showed total mutagenic effect of 
INH with probability of 100%. From H, the predicted results 
depicted in Table4, indicate the reduction in the mutagenic 
effect from 100% to 71% in. In the literature, studies 
indicated that the hepatotoxic effect of IZD can lead to the 
genetic variations in enzymes in Asian populations 
(Caucasian population)11. These variations could be 
attributed to the interaction between IZD-reactive 
metabolites with DNA.      
 
Table 4: Mutagenicity prediction of IZD, and H 
Compounds Prediction Probability % 
IZD Active 100 
H Active 71 
 
The high mutagenic effect of H when it was detected in 
substructure prediction could be explained by the presence 
of nitro-aromatic fragment in the structure. In the 
biotransformation, aromatic nitro group is involved in 
enzymatic reduction, catalyzed by both cytosolic and 
microsomal enzymes, leading to the formation of aromatic 
hydroxylamine intermediate. Then, this intermediate is 
activated to nitronium ion intermediate that covalently bind 
to DNA and as a result causes mutation9 (Fig. 1). 
 
Fig.1: Proposed mechanism of H biotransformations to their reactive metabolite, nitrenium ion intermediate9. 
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Antibacterial effect evaluation 
Fish infection caused the decrease in marine productivity, 
and heavy economic costs12. This problem led to search of 
new safe antibiotics for marine uses. For this reason, the 
hydrazone H was examined for their bactericidal effect 
towards tow marine pathogenic bacteria; Vibrio anguillarum 
and Photobacterium damselae. The results displayed in Fig.2. 
indicate an excellent bactericidal effect of H against Vibrio 
anguillarum with inhibition percentages of 98.38% and 
98.65% at 500 µg/mL and 1000 µg/mL respectively. Also, IH 
exhibited good effect against Photobacterium damselae with 
inhibition percentages of 97.79% and 97.74% at the same 
concentrations respectively. 
  
 
Fig.2: bactericidal effect of H   
 
In silico anti-tubercular activity evaluation 
According to World Health Organization statistics, 
tuberculosis is the principle infectious disease responsible of 
mortality in the word13, which leads to search of potential 
anti-tubercular drugs14. In this context, the computational 
study is the essential step for the designing of new efficient 
drugs. The hydrazone H was investigated for these effects. 
The predicted results (Fig.3) were compared with the anti-
tubercular drug IZD, and indicated excellent effects of this 
hydrazone with probabilities of anti-tubercular effects of 
84.6, while the standard anti-tubercular drug IZD has the 
probability of 81.3 %. These results showed that H has 
higher effect than IZD. These results are in good agreement 
with the literature precedent investigations, which showed 
that hydrazones derived from IZD have a similar or 
improved effect than the drug itself15. 
 
 Fig.3: Anti-tubercular activity prediction of H and IZD 
Molecular docking 
Molecular docking study was performed to predict the 
possible binding modes and to rationalize the observed 
biological activity16. In order to comprehend the mechanism 
of action of the new hydrazones, the active molecules were 
subjected to molecular docking studies against InhA which is 
considered as a promising target for the discovery of novel 
anti-tubercular drugs17. The molecular docking studies of 
active compounds were accomplished against the active site 
of InhA enzyme structure (PDB code: 4DRE) using SwissDock 
server. FullFitness and Gibbs free energy (ΔG) were 
evaluated. Favorable binding modes were scored based on 
FullFitness and cluster formation. Ranking of the cluster was 
accomplished using the value of FullFitness. As shown in 
Table 5, the clustering results obtained from the docking of 
the investigated hydrazones into InhA enzyme. H showed 
FullFitness values of –1084.565 kcal/mol and estimated ΔG 
of –7.187 kcal/mol, for the most favorable interaction. While, 
IZD showed FullFitness of –1088.536 kcal/mol and ΔG value 
of 6.458 kcal/mol. These results indicate that H had the 
highest anti-tubercular activity with the lowest energy ΔG. 
The best poses obtained using SwissDock server for the 
synthesized compounds binding to enoyl ACP reductase 
(InhA) enzyme are presented in Fig. 4, which showed 
different interactions traduced by H-bonds (green color). It’s 
clear that H possess two centers of interaction; O of the 
amide and O of the nitro group. The standard drug IZD has 
two interaction centers of H-bonds, O of amide and N of 
hydrazine function. 
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Table 5: Clustering results obtained from the docking of IZD and H InhA. 
Compounds Cluster rank Fullfitness 
kcal/mol 
Estimated 
ΔG kcal/mol 
 
 
H 
1 –1084.565 –7.187 
2 –1084.455 –7.141 
3 –1071.394 –7.142 
4 –1068.268 –7.138 
5 –1068.057 –6.999 
 
 
IZD 
1 –1088.536 –6.458 
2 –1086.227 –6.157 
3 –1083.790 –6.073 
4 –1083.735 –6.068 
5 –1079.096 –6.104 
 
 
Fig. 4: Visualization of binding of H to enoyl ACP reductase 
(InhA) enzyme (PDB code: 4DRE), Visualization is 
performed using UCSF Chimera. 
CONCLUSION 
In silico toxicological studies were undertaken using online 
software programs; from toxicophores, acute toxicity, and 
mutagenicity; these studies showed low toxic effect of H with 
predicted LD50values of 1816 mg/kg. Additionally, reduction 
in the mutagenic effect was observed with probability value of 
29%. The anti-tubercular effect was predicted, results 
demonstrated the persistence of the effect in the investigated 
compound with predicted value of 84.6 %. Results of in vitro 
bactericidal effect evaluation using microorganism (Vibrio 
anguillarum and Photobacterium damselae) indicated an 
excellent effect of this compound at the doses of 1000 and 500 
µg/mL. We conclude that the hydrazone can be a marine 
antibiotic. 
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